Todas as matérias desta seção, das mais recentes às mais antigas — página 175 de 371.
Pony AI (NASDAQ:PONY) recorded a 145% surge in first-quarter revenue, fueled by the rapid commercial acceleration of its robotaxi operations, leading the autonomous driving company to raise its full-year vehicle deployment and revenue targets.
Yatsen Holding (NYSE:YSG) reported a 22.5% increase in first-quarter revenue, driven by accelerating consumer demand for its skincare portfolio, though aggressive promotional spending and higher research outlays widened its net loss.
MINISO Group Holding (NYSE:MNSO) reported a 28.5% increase in revenue for the March quarter, matching capital market expectations as the value lifestyle retailer expanded its domestic and international store networks.
Sunlands Technology Group (NYSE:STG) preserved its four-year streak of consecutive quarterly profitability during the first quarter, relying on aggressive structural cost-cutting to mitigate a slide in net revenues and new student enrollments.
VNET Group (NASDAQ:VNET) recorded a 19.8% increase in first-quarter revenue, driven by accelerating enterprise demand for its wholesale data center space, even as one-off tax expenses tied to capital transactions widened its net loss.
BioArctic announced that its long-term development and commercialization partner, Eisai, has presented an updated financial simulation outlining the growth trajectory for their co-developed Alzheimer’s disease treatment, Leqembi (lecanemab).
JOYY (NASDAQ:JOYY) recorded its fastest pace of revenue growth in recent years during the first quarter, driven by a sharp acceleration in its digital advertising business, and authorized an aggressive three-year, $1.5 billion shareholder return initiative.
Elbit Systems (NASDAQ:ESLT) won a contract valued at approximately $1.4 billion from an undisclosed European customer to execute a comprehensive military modernization initiative spanning the next five years.
LexinFintech Holdings (NASDAQ:LX) announced its unaudited financial results for the first quarter ended March 31, 2026, delivering steady top-line growth driven by an accelerating e-commerce sector, despite a substantial year-over-year contraction in net profit.
The U.S. Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan-dlnk) for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy.
Agios Pharmaceuticals (NASDAQ:AGIO) announced that the European Commission has granted marketing authorization for Pyrukynd (mitapivat) to treat anemia in adult patients with alpha- or beta-thalassemia.
Imperial Petroleum (NASDAQ:IMPP) announced its financial and operational results for the first quarter of 2026, marking the second-best quarterly performance in the ship-owning company’s history.
Functional Brands (NASDAQ:MEHA) announced it has signed a definitive agreement to acquire the Alchemy gold-backed blockchain settlement and decentralized finance (DeFi) platform from BullionFX.
Quanta Services (NYSE:PWR) announced today that its board of directors has authorized a new $1 billion stock repurchase program and declared its latest quarterly cash distribution.
Assembly Biosciences (NASDAQ:ASMB) announced plans to expand the clinical development framework for its experimental compound ABI-6250, pushing the asset beyond its initial virology target into chronic cholestatic liver conditions.
Enhertu (trastuzumab deruxtecan) moved a step closer to a milestone regulatory approval in Europe, securing a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) as a tumor-agnostic treatment for advanced solid malignancies.
AbbVie (NYSE:ABBV) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Maviret (glecaprevir/pibrentasvir) for the treatment of acute hepatitis C virus (HCV) infection.
Global Ship Lease (NYSE:GSL) reported elevated top-line growth and resilient cash generation for the first quarter of 2026, insulating its balance sheet from broader maritime macro-volatility through defensive multi-year charter coverage.
BioLineRx (NASDAQ:BLRX) and Hemispherian announced that two abstracts featuring their experimental oncology compound, GLIX1, will be published at the upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting.
ImmunityBio (NASDAQ:IBRX) announced new survey data highlighting the highly individualized treatment preferences and quality-of-life priorities of patients navigating high-risk non-muscle-invasive bladder cancer (NMIBC).
AC Immune (NASDAQ:ACIU) announced positive preliminary Phase 1 clinical data for its experimental brain imaging agent, ACI-19626, expanding its diagnostic reach into amyotrophic lateral sclerosis (ALS).
Booz Allen Hamilton Holding (NYSE:BAH) announced its preliminary financial results for the fourth quarter of fiscal year 2026, delivering an uptick in profitability and backlog expansion despite a contraction in top-line revenue.
BJ’s Wholesale Club Holdings (NYSE:BJ) reported a slight decline in first-quarter net income, as aggressive pricing strategies and rising overhead from footprint expansion offset resilient gains in membership fee revenue.
LyondellBasell Industries (NYSE:LYB) announced today that its board of directors has declared a quarterly cash dividend of $0.69 per share.
